JANX — Janux Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Janux Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.658	7.81	375	327	344
Net Total Accounts Receivable
Net Total Receivables	0	8	0	—	—
Prepaid Expenses
Total Current Assets	0.658	16.1	377	332	349
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.021	0.155	1.6	29.4	27.8
Other Long Term Assets
Total Assets	0.679	16.2	380	364	380
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.63	3.18	12.8	16.5	13
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.63	9.23	13.5	43.3	36.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-3.95	6.99	366	321	344
Total Liabilities & Shareholders' Equity	0.679	16.2	380	364	380
Total Common Shares Outstanding